WSHP — Wasatch Pharmaceutical Income Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual income statement for Wasatch Pharmaceutical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
1998 December 31st | 1999 December 31st | 2000 December 31st | 2001 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | 10KSB | 10KSB | 10KSB | 10KSB |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0.081 | 0.044 | 0.03 | 0.053 |
| Cost of Revenue | ||||
| Gross Profit | 0.076 | 0.041 | 0.026 | 0.035 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 1.54 | 1.21 | 2.38 | 3.19 |
| Operating Profit | -1.46 | -1.17 | -2.35 | -3.14 |
| Net Income Before Taxes | -1.46 | -1.17 | -2.35 | -3.14 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -1.46 | -1.17 | -2.35 | -3.14 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -1.46 | -1.17 | -2.35 | -3.14 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Dilution Adjustment | ||||
| Diluted Net Income | -1.46 | -1.17 | -2.35 | -3.14 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -176,057 | -166,849 | -183,680 | -42,748 |
| Dividends per Share |